Rita Nanda, MD
Rita Nanda, MD, is an Associate Professor of Medicine and co-Director of the Breast Medical Oncology Program at the University of Chicago. Dr. Nanda earned her undergraduate degree in Chemical Engineering from the Massachusetts Institute of Technology. She received her Medical Degree from The University of Chicago, Pritzker School of Medicine, and subsequently completed her Residency in Internal Medicine and her Fellowship in Hematology/Oncology at the University of Chicago Medical Center.
Dr. Nanda’s research interests include identifying novel treatments for the management of breast cancer, particularly triple-negative breast cancer. She leads the University of Chicago’s clinical and translational breast cancer research efforts and serves as a Principal Investigator for the Translational Breast Cancer Research Consortium (TBCRC) and the ISPY2 Clinical Trial. She is a member of multiple professional organizations, including the American Society of Clinical Oncology, the American Association of Cancer Research, and the Society for Immunotherapy of Cancer.
Dr. Nanda has authored numerous scientific publications, including one of the first reports of immune checkpoint inhibitor therapy for triple-negative breast cancer. She has been invited to present her research at multiple national and international conferences. In recognition of her dedication to breast cancer research, Dr. Nanda has earned numerous awards, including the 2014 NCI Cancer Clinical Investigator Team Leadership Award.